Lido Advisors LLC Buys New Holdings in Tenet Healthcare Corporation $THC

Lido Advisors LLC purchased a new position in shares of Tenet Healthcare Corporation (NYSE:THC) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 2,263 shares of the company’s stock, valued at approximately $427,000.

A number of other hedge funds also recently made changes to their positions in the business. Triumph Capital Management bought a new position in shares of Tenet Healthcare during the 3rd quarter worth approximately $25,000. Activest Wealth Management bought a new stake in Tenet Healthcare in the 4th quarter valued at $26,000. Elyxium Wealth LLC acquired a new stake in Tenet Healthcare during the 4th quarter valued at $29,000. Meeder Asset Management Inc. lifted its stake in shares of Tenet Healthcare by 146.2% during the 4th quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock worth $38,000 after buying an additional 114 shares during the last quarter. Finally, Canada Pension Plan Investment Board bought a new stake in shares of Tenet Healthcare during the 2nd quarter worth about $35,000. 95.44% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have weighed in on THC. Wall Street Zen raised shares of Tenet Healthcare from a “hold” rating to a “buy” rating in a report on Sunday, July 26th. Stephens reaffirmed an “overweight” rating and issued a $285.00 target price on shares of Tenet Healthcare in a research report on Monday. KeyCorp lowered their target price on Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating on the stock in a research note on Friday, May 1st. Morgan Stanley boosted their price target on Tenet Healthcare from $254.00 to $274.00 and gave the company an “overweight” rating in a research note on Monday. Finally, Raymond James Financial set a $270.00 price objective on Tenet Healthcare in a report on Monday. Seventeen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $268.50.

Tenet Healthcare Stock Performance

Shares of NYSE:THC opened at $254.88 on Friday. Tenet Healthcare Corporation has a 12-month low of $156.71 and a 12-month high of $262.68. The company’s 50 day moving average price is $192.10 and its two-hundred day moving average price is $199.35. The firm has a market cap of $21.96 billion, a PE ratio of 9.83, a PEG ratio of 0.96 and a beta of 1.27. The company has a quick ratio of 1.35, a current ratio of 1.41 and a debt-to-equity ratio of 2.00.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. The company had revenue of $6.04 billion during the quarter, compared to the consensus estimate of $5.43 billion. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the previous year, the business earned $4.02 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Equities research analysts predict that Tenet Healthcare Corporation will post 21.09 earnings per share for the current year.

Insider Transactions at Tenet Healthcare

In related news, Director J Robert Kerrey sold 5,638 shares of the business’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $174.52, for a total value of $983,943.76. Following the completion of the transaction, the director owned 16,804 shares of the company’s stock, valued at $2,932,634.08. The trade was a 25.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Lisa Y. Foo sold 10,000 shares of the company’s stock in a transaction dated Wednesday, July 29th. The stock was sold at an average price of $258.03, for a total transaction of $2,580,300.00. Following the sale, the executive vice president directly owned 32,053 shares of the company’s stock, valued at $8,270,635.59. This represents a 23.78% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 33,353 shares of company stock worth $7,683,517. Corporate insiders own 0.97% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.